PURPOSE: Dose verification in preclinical radiotherapy is often challenged by a lack of standardization in the techniques and technologies commonly employed along with the inherent difficulty of dosimetry associated with small-field kilovoltage sources. As a...
Xstrahl would like to invite you to explore several new treatment and preclinical research advancements at the annual ASTRO meeting on September 15th-18th in Chicago. Xstrahl is launching a new image-guidance system, a sleek and streamlined way of giving clinicians a...
Bowen’s disease is a type of squamous cell carcinoma (SCC) in situ of the skin usually characterized by slow-growing, red and scaly patches of skin. Bowen’s disease can be symptomatic and can progress to invasive SCC causing morbidity and even mortality. In their...
August 26th, 2019 The new SARRP beamline pre-clinical radiation research and CT imaging platform launched at the Xstrahl booth at ICRR in Manchester, UK, August 25th-29th Xstrahl Life Science, global leader in the development of advanced X–ray systems for pre-clinical...
August 26th, 2019 Xstrahl Life Science, global leader in advanced radiation research systems, is introducing a Monte Carlo dose engine to enable comparative research work to be carried out on its Small Animal Radiation Research Platform (SARRP) system. The new...
Small animal radiotherapy research platforms such as Xstrahl's SARRP enable more precise irradiation of tumours and normal tissues in pre-clinical models of cancer. In their study “Evaluation of four different small animal radiation plans on tumour and normal tissue...
In their paper “Interleukin 6 Signaling Blockade Exacerbates Acute and Late Injury From Focal Intestinal Irradiation” Bell BI, Koduri S, Salas Salinas C, et al, aim to evaluate the acute changes in leukocyte populations after focal irradiation and to assess the role...
Radiotherapy is recognized as one of the main modalities for the treatment of cancer in the world, the translation of the results of the pre-clinical research to clinical trials represents an optimization of the resources destined to combat this disease. Improvements...
Meningiomas are a frequent tumor of the central nervous system. Although mostly benign, approximately 5% present as atypical or malignant tumors. Treatments for atypical meningiomas include gross total resection and radiotherapy, but about 33% of patients have...
Contact Us